Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and [18F]deuteroaltanserin

This publication has 22 references indexed in Scilit:

• Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
  NeuroImage, 1997
• Time Course of 5-HT2A Receptor Occupancy in the Human Brain after a Single Oral Dose of the Putative Antipsychotic Drug MDL 100,907 Measured by Positron Emission Tomography
  Neuropsychopharmacology, 1997
• [11C]MDL 100907, a radioligand for selective imaging of 5-HT2A receptors with positron emission tomography
  Life Sciences, 1996
• Serotonin 5HT₂ Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [¹⁸F]Altanserin: Results in Young Normal Controls
  Journal of Cerebral Blood Flow & Metabolism, 1995
• Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1994
• Evaluation of Ultrafiltration for the Free‐Fraction Determination of Single Photon Emission Computed Tomography (SPECT) Radiotracers: β‐CIT, IBF, and Iomazenil
  Journal of Pharmaceutical Sciences, 1994
• MRI-PET Registration with Automated Algorithm
  Journal of Computer Assisted Tomography, 1993
• Loss of brain 5-HT₂receptors in Alzheimer's disease
  Brain, 1993
• [18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo
  European Journal of Pharmacology, 1988
• A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
  Annals of Neurology, 1984